ID
33151
Descrizione
Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains Vital signs . It has to be filled in for study visit.
collegamento
https://clinicaltrials.gov/ct2/show/NCT00599612
Keywords
versioni (1)
- 29/11/18 29/11/18 -
Titolare del copyright
GlaxoSmithKline
Caricato su
29 novembre 2018
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Safety, tolerability, excretion balance and pharmacokinetics of Losmapimod in healthy males, NCT00599612
Similar models
Vital signs
- StudyEvent: ODM
C0038846 (UMLS CUI [1,2])
C0038846 (UMLS CUI [1,2])